A new study from Joslin Diabetes Center may shed light on why some people can eat excessive amounts of food and not gain weight or develop type 2 diabetes, while others are more likely to develop obesity and this most common form of diabetes on any diet.
Use of growth hormone to boost athletic performance can lead to diabetes, reports a study published ahead of print in the British Journal of Sports Medicine.
Drinking a nice warm cup of green tea has long been touted for its healthful benefits, both real and anecdotal. But now researchers have found that a component of green tea, combined with low doses of a COX-2 inhibitor, could slow the spread of human prostate cancer.
Using a $2.5 million, three-year grant from the Juvenile Diabetes Research Foundation (JDRF), Emory transplant researchers plan to develop pig islets as an alternative to human islets for transplant into patients with Type 1 diabetes. If their research is successful, clinical trials of the porcine islet transplants into humans could begin within the next three years.
A Georgetown medical professor cuts through hype surrounding weight-loss supplements with new science-based guide.
A new study in rats reveals black soya beans that a diet rich in could help control weight, lower fat and cholesterol levels, and help in the prevention of diabetes. Researchers have shown that rats fed with 10 percent soya had gained half as much weight as those without. Total blood cholesterol fell by 25 percent and LDL (so-called bad) cholesterol fell by 60 percent. Preventing obesity this way may also aid diabetes prevention.
Use of growth hormone to boost athletic performance can lead to diabetes, reports a study published ahead of print in the British Journal of Sports Medicine.
Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Eli Lilly and Company (NYSE: LLY) announced that the U.S. Food and Drug Administration (FDA) has approved more convenient patient storage instructions for BYETTA? (exenatide) injection.
Eli Lilly and Company today announced the launch of the first insulin pen with memory, HumaPen? MEMOIR?, to help simplify the daily management of diabetes.
Diabetes management can be overwhelming, and data shows less than half of the 15 million being treated for diabetes have blood sugar levels within the recommended range.